Lymphoma News

CHICAGO – In this Healio video exclusive, Christopher Flowers, MD, discusses how the combination of zanubrutinib and obinutuzumab vs. obinutuzumab alone leads to longer PFS in patients with relapsed/refractory follicular lymphoma.

CHICAGO - In this video, Reid Merryman, MD, discusses updates on a trial testing the combination of epcoritamab, rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma.

In this video, Jakub Svoboda, MD, discusses the results of a large real-world study on brexu-cel for mantle cell lymphoma, which were presented at ASCO Annual Meeting.

In this video, Jakub Svoboda, MD, discusses an update on pirtobrutinib, which was recently approved for relapsing mantle cell lymphoma that has been previously treated with Bruton tyrosine kinase inhibitors.

In this video, Joshua Brody, MD, discusses the results of the IELSG37 randomized trial, which examined whether radiotherapy is necessary after front-line chemoimmunotherapy for patients with primary mediastinal B-cell lymphoma.

Continued administration of COVID-19 booster vaccine among patients with lymphoma appeared associated with lower COVID-19 breakthrough infection rates, according to data published in The Lancet.

Falls in an inpatient cancer rehabilitation unit occurred less frequently than previous studies have estimated and usually caused patients no harm, according to data published in JCO Oncology Practice.

Women receiving cancer treatment in clinical trials exhibited higher risk for severe symptomatic and hematologic adverse events than their male counterparts, according to a study.

Pirtobrutinib appeared effective among a cohort of heavily pretreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma, according to study results published in The New England Journal of Medicine.

Treatment with anthracyclines for breast cancer or lymphoma correlated with more than two times higher risk for congestive heart failure than that of healthy controls, according to a study conducted at Mayo Clinic.